Medtech Talk

Cynthia Yee, a principal at Windham Venture Partners, opened her firm’s office in San Francisco. Yee shares her opinions on many medtech questions including 510(k) versus PMA, the power of payers, and how younger professionals view careers in medtech.

The Medtech industry earns only passing grades in the category of product design, according to product development group Nottingham Spirk. But the company hopes to leverage its experience and access to capital to help Medtech start-ups get to the head of the class.

HealthQuest Capital secured a $225 million fund to invest in new health care technologies. Managing Director Garheng Kong, MD, explains the firm’s views on health care, how doctors view new technologies and what competitive volleyball can teach us about venture investing.

Experienced medtech CEO Kerry Pope explains how the Fogarty Institute is building coalitions of corporations and entrepreneurs to create medtech start-ups.

Outset Medical CEO Leslie Trigg brings a career of success in medtech into a new approach to dialysis. Tablo, a sleek device, could enable dialysis companies an easier, cheaper way of providing dialysis to patients.

As CEO, Kevin Hykes led two companies – Visiogen and Cameron Health – to successful acquisitions by strategic acquirers. In this interview, Hykes shares the lessons learned from leading those companies and explains how he’s adapting to life as CEO of an early-stage company.

Justin Klein, MD, JD, sits down with Healthegy TV to provide details on where his firm, New Enterprise Associates, sees the greatest opportunities in Medtech. He also explains how a firm with $3 billion to manage still makes early-stage investments.

For the past two decades, Josh Makower, MD, has sat on the innovator’s side of the table creating innovations and innovators through his work with the Exploramed incu-bator and Stanford Biodesign Program. Now, Makower takes his considerable abilities to New Enterprise Associates, where he’ll invest in medtech companies on behalf of one of the indus-try’s most venerable firms. Hear where he sees opportunity and how Astronaut Steve Austin in-fluenced his career path.

Jason Lettman, partner at Lightstone Ventures, set up shop in Ireland after Lightstone closed its debut fund. Hear how he views Medtech from the other side of the Atlantic.

Oculeve, a stealthy start-up with backing from Kleiner, NEA and Versant, opted to sell its neurostim treatment for Dry Eye to Ophthalmology Leader Allergan.